Talcum Powder Lawsuit Updates
Last updated: September 3, 2026
Johnson & Johnson tried three times to settle the ovarian cancer talc claims through bankruptcy, and courts rejected all three. In July 2026 the company announced a settlement of roughly $5.5 billion instead, negotiated in the ordinary court system. This page covers where that stands, who it covers, and who it leaves out.
This page is general legal education, not legal advice, and it reports on litigation that is still moving. Nothing here evaluates any individual reader’s claim or creates an attorney-client relationship.
Where the Talc Litigation Stands Now
The federal talc cases are grouped together before one judge in New Jersey, Judge Michael A. Shipp, in what the courts call MDL 2738. Reported counts put it above 69,250 pending cases as of September 1, 2026, up from about 68,900 in early August and roughly 68,000 in June. It has been the largest active group of federal cases of its kind for some time, and it kept growing even as the settlement was announced.
Thousands of additional cases sit in state courts, which matters more here than in most mass torts because the biggest verdicts have come from state juries rather than the MDL. For the underlying allegations see Talcum Powder Ovarian Cancer Lawsuit, and for the asbestos contamination question see Which Talcum Powder Brands Have Faced Asbestos Concerns?
Talc claims are still being filed. A settlement in principle is not the same as a closed docket, and eligibility still turns on diagnosis, product use history, and the deadlines in your state.
Check Whether You May QualifyThe July 2026 Settlement, and What It Covers
In late July 2026, Johnson & Johnson agreed to pay a reported $5.5 billion to settle the ovarian cancer talc claims. J&J's filing says the first payment will be no more than $3 billion in 2027, with nothing further due before 2028. The deal covers most of the remaining ovarian cancer claims in both state and federal court.
Does it cover you?
If you have an ovarian cancer claim already filed, most likely yes. Three groups are outside it. Mesothelioma claims are on a separate track. Cases outside the United States are unaffected. And anyone who has not filed yet is not automatically part of anything.
It is not final, and that matters
J&J's own filing with the SEC puts the condition at 95 percent. At least that share of the remaining claims has to take part before the deal goes ahead. It does not happen on its own. Whether individual people agree to join still decides whether it goes ahead at all, which is unusual and worth understanding if you have a claim.
What is still unknown
Payments are described as being set by a tiered grid based on objective features of each claim, and plaintiffs' counsel have said the fund is uncapped rather than a fixed pot divided among everyone. What has not been published is the grid itself. No per-claim figures are public, so anyone quoting you a number for your own case is estimating, not quoting the settlement.
One more thing about how this came about. J&J tried three times to cap its talc liability by putting a subsidiary into bankruptcy. Courts rejected all three, the last in 2025. That is why this settlement had to be negotiated in ordinary court, and it is why it can be turned down by claimants rather than imposed on them.
What has happened recently
- July 2026, the settlement was announced. J&J agreed to pay a reported $5.5 billion to resolve the ovarian cancer claims. Reporting put the number of claims covered at around 76,000, across both state and federal courts. It only takes effect if enough claimants agree to it.
- July 2026, the court asked for proof on causation. The federal judge told plaintiffs to come forward with evidence that talc caused their particular cancer, after J&J pushed to have the ovarian cases thrown out. That continued alongside the settlement talks rather than pausing for them.
- Through mid-2026, state court verdicts went both ways. A Minnesota court left a $65.5 million mesothelioma verdict standing, and a Los Angeles jury awarded $32 million in a death from pleural mesothelioma. In the same stretch another California jury found for J&J in an ovarian cancer case, and a Los Angeles judge threw out a $950 million punishment award while leaving the rest of that verdict in place.
- Earlier in 2026, the judge ordered both sides into mediation. He appointed an experienced mediator and required both sides to send people who could actually agree to a deal. That ran through the first half of the year and led to the July announcement.
- 2025, the third bankruptcy attempt failed. A bankruptcy court rejected J&J's plan, ending its third try at capping talc liability by putting a subsidiary into bankruptcy. That is why the 2026 settlement had to be negotiated in the ordinary court system instead.
Mesothelioma claims are separate, and this settlement does not cover them
Talc litigation has always had two sides, and they are proven in different ways.
Ovarian cancer claims are about long-term use of talc powder. Mesothelioma claims are about asbestos found in the talc itself, and they are proven the way any asbestos case is: where and when someone was exposed, which product it was, and what the pathology shows.
That is why the July settlement is described as an ovarian cancer settlement. If you have a mesothelioma diagnosis connected to talc, your claim sits with the wider asbestos litigation rather than inside this settlement. See Mesothelioma Lawsuit and Asbestos Exposure Lawsuits.
A settlement does not extend your deadline
This is the part worth acting on. Filing deadlines for talc claims are set by state law and are usually tied to the date of diagnosis. A settlement being announced does not pause them, extend them, or protect anyone who has not filed. If a diagnosis is recent, timing is normally the first thing a lawyer looks at.
What to watch from here
- Whether enough claimants accept the deal for it to take effect.
- How payments would be divided up and on what schedule.
- What happens to people who do not join it.
- New cases still being filed, which had not slowed as of early August 2026.
- How the federal court rules on the causation evidence it asked for.
- State court mesothelioma verdicts, which sit outside the settlement entirely.
How This Updates Page Fits With the Main Talc Page
The main Talcum Powder Ovarian Cancer Lawsuit page covers who the litigation involves, what is alleged, and how claims are evaluated. That material changes slowly. This page tracks docket movement and settlement status, which change often. Background on the science sits on Is Talcum Powder Safe? and Which Talcum Powder Brands Have Faced Asbestos Concerns?
Case counts, settlement terms, and court schedules reported here reflect public reporting available on the date above and should be confirmed against the docket before being relied on.
Related Lawsuit Topics
Talcum Powder Ovarian Cancer Lawsuit
The main overview of who is involved and what is alleged.
Is Talcum Powder Safe?
What the research says about talc and cancer risk.
Talcum Powder Brands and Asbestos
Which products have faced asbestos contamination concerns.
Mesothelioma Lawsuit
How mesothelioma claims work, including talc-related ones.
Reproductive Injuries Linked to Lawsuits
Other litigation involving reproductive cancers and conditions.
Mass Torts
How MDLs, bellwethers, and global settlements actually work.
Find Out If You May Have a Case
If you or a family member used talc products for years and were later diagnosed with ovarian cancer or mesothelioma, a free case review can tell you two things. Whether that history fits a claim, and whether your state's deadline still allows one.
Free and no obligation. Lawsuit Center is not a law firm and submitting a request does not create an attorney-client relationship.
